BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 9759582)

  • 1. Vaccines and other adjuvant therapies for melanoma.
    Wolchok JD; Livingston PO; Houghton AN
    Hematol Oncol Clin North Am; 1998 Aug; 12(4):835-48, vii. PubMed ID: 9759582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of melanoma.
    Brown CK; Kirkwood JM
    Surg Clin North Am; 2003 Apr; 83(2):283-322, viii. PubMed ID: 12744611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant immunotherapy for melanoma.
    Thomas D; Bello DM
    J Surg Oncol; 2021 Mar; 123(3):789-797. PubMed ID: 33595889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of adjuvant therapy in cutaneous melanoma.
    Sondak VK
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):421-6. PubMed ID: 12113108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma adjuvant therapy.
    Tarhini AA; Thalanayar PM
    Hematol Oncol Clin North Am; 2014 Jun; 28(3):471-89. PubMed ID: 24880942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapies.
    Kirkwood JM
    Eur J Cancer; 1998 Jul; 34 Suppl 3():S12-7. PubMed ID: 9849403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging therapies for melanoma.
    Katipamula R; Markovic SN
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate- and high-risk melanoma.
    Agarwala SS
    Curr Treat Options Oncol; 2002 Jun; 3(3):205-17. PubMed ID: 12057066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.
    Batliwalla FM; Bateman BA; Serrano D; Murray D; Macphail S; Maino VC; Ansel JC; Gregersen PK; Armstrong CA
    Mol Med; 1998 Dec; 4(12):783-94. PubMed ID: 9990864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Neo)adjuvant systemic therapy for melanoma.
    van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
    Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new in the treatment of cutaneous melanoma?
    Olhoffer IH; Bolognia JL
    Semin Cutan Med Surg; 1998 Jun; 17(2):96-107. PubMed ID: 9669603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for combining chemotherapy and biotherapy in melanoma.
    Buzaid AC
    Cancer Control; 2000; 7(2):185-97. PubMed ID: 10783824
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
    Mitchell MS; Abrams J; Thompson JA; Kashani-Sabet M; DeConti RC; Hwu WJ; Atkins MB; Whitman E; Ernstoff MS; Haluska FG; Jakowatz JG; Das Gupta TK; Richards JM; Samlowski WE; Costanzi JJ; Aronson FR; Deisseroth AB; Dudek AZ; Jones VE
    J Clin Oncol; 2007 May; 25(15):2078-85. PubMed ID: 17513813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma vaccines.
    Perales MA; Wolchok JD
    Cancer Invest; 2002; 20(7-8):1012-26. PubMed ID: 12449735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does adjuvant vaccine therapy really have activity in malignant melanoma?
    Wheatley K; Ives NJ; Lorigan P
    J Clin Oncol; 2007 Oct; 25(29):4693; author reply 4693-5. PubMed ID: 17925569
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of melanoma vaccines: active specific immunotherapy for melanoma patients.
    Ollila DW; Kelley MC; Gammon G; Morton DL
    Semin Surg Oncol; 1998 Jun; 14(4):328-36. PubMed ID: 9588726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy and experimental approaches for metastatic melanoma.
    Atkins MB
    Hematol Oncol Clin North Am; 1998 Aug; 12(4):877-902, viii. PubMed ID: 9759585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First International Symposium on Melanoma and Other Cutaneous Malignancies.
    Tarhini AA; Agarwala SS
    Expert Opin Biol Ther; 2004 Sep; 4(9):1541-6. PubMed ID: 15335320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary treatment of primary melanoma.
    Yao K; Balch G; Winchester DJ
    Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.